MRMegan Racey

Megan Racey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Megan Racey has a total of 185 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Ready, Set, Go? A Qualitative Case Study Exploring Implementation Readiness of a Type 2 Diabetes Remission Program in a Primary Care Setting Using a Scalability Assessment

    by Raluca Vela, Susan M. Jack, Melissa Northwood, Brian McKenna, Julia Roglich, Paige Alliston, Megan Racey, John-Michael Gamble, Hertzel C. Gerstein, Natalia McInnes, et al.

  • Open Access

    Rethinking obesity management targets: Findings from an international MoSCoW prioritization workshop

    by Sanjeev Sockalingam, Megan Racey, Diana Sherifali, Angela S. Alberga, Jamy Ard, Deborah Bade Horn, Luca Busetto, Lee M. Kaplan, Carel W. Le Roux, David Macklin, et al.

  • Open Access

    Better way: initial acceptability testing of using artificial intelligence tools to accelerate development of trauma clinical guidance

    by Gabriela Zavala Wong, Shannon Rosenauer, Chelsea Church, Diana Sherifali, Megan Racey, Katheryn Grider, Ashley N Moreno, Lacey LaGrone, Pamela Bixby

    Introduction: Representatives of the trauma community have voiced a need for a new approach to developing clinical guidance. In this study, we test the initial acceptability of a proposed 12-step approach that aims to reduce the current clinical guidance timeline from more than 24 months to 24 weeks. Methods: Investigators hypothesized that artificial intelligence (AI) tools could be leveraged to improve and make the process of clinical guidance development more efficient, facilitating AI initial output that could later be reviewed by subject matter experts (SMEs), ensuring ethical standards and a collaborative design. Following the agile methodology, emphasizing continuous delivery and improvement, and the Practical, Robust Implementation and Sustainability Model framework, the investigators drafted a 12-step approach to clinical guidance development in 24 weeks. The process begins with selecting a clinical topic and culminates in a bedside-ready clinical decision tree. Results: The 2025 Design for Implementation: The Future of Trauma Research & Clinical Guidance conference participants were invited to reflect on this new 12-step approach during two breakout sessions. Participants included a broad range of trauma providers, methodologists, patient representatives, technology, and marketing experts. Their recommendations highlighted: (1) multidisciplinary involvement, (2) need for resource-stratified guidance, and (3) user-friendly features (offline and multilingual access). On a postconference survey (n=56 total respondents), 64% were confident in AI accelerating the current development process. Conclusions: The current landscape of clinical guidance offers significant opportunities for improvement. Key areas for improvement include promoting collaboration across multiple disciplines and organizations, developing recommendations that consider resource variations, and leveraging new technologies, such as AI, to expedite the development process. This is crucial because ongoing delays lead to practices lagging behind current evidence. Further research is needed to rigorously test and refine how responsible use of AI can be integrated into expediting evidence integration into clinical guidance.

  • Type 2 Diabetes Remission: A Systematic Review and Meta-analysis of Nonsurgical Randomized Controlled Trials

    by Diana T Sherifali, Megan E Racey, Michelle K Greenway, Paige E Alliston, Muhammad U Ali, Hertzel C Gerstein, Integrated Knowledge Translation (Ikt) Type 2 Diabetes Remission Advisory Team

    BACKGROUND: Evidence that type 2 diabetes can be reversed has been limited by the understanding and implementation of these interventions. PURPOSE: We assessed the effect of nonsurgical randomized controlled trials (RCTs) on type 2 diabetes remission and characterized core components. DATA SOURCES: We reviewed articles from MEDLINE and Embase (inception to April 2025). STUDY SELECTION: RCTs of multimodal pharmacological or nonpharmacological type 2 diabetes remission interventions for adults with type 2 diabetes were included. DATA EXTRACTION: Study characteristics and outcomes for clinical/population health, patient-reported, and adverse event were extracted. DATA SYNTHESIS: We performed a random-effects multilevel meta-analysis of studies, grouped based on type of intervention and by length of follow-up. A total of 18 studies were included in this review from 11 different countries. There was a higher likelihood of achieving type 2 diabetes remission through multimodal interventions (risk ratio [RR] 1.75 [95% CI 1.49–2.04]) and for nonpharmacological interventions (RR 5.80 [95% CI 4.28–7.87]), compared with the control group. Other significant outcomes for intervention groups compared with control groups included change in A1C, weight loss, and quality of life and improvements in adverse events of hypoglycemia. LIMITATIONS: There was heterogeneity in our small pool of included studies (diversity of nonpharmacological components), stringent intervention protocols, narrow participant selection criteria, and lack of consistent diabetes remission definitions. CONCLUSIONS: With specific protocols, a variety of tailored approaches can induce type 2 diabetes remission for patients with newly diagnosed type 2 diabetes who are able to subscribe to strict protocols. Consideration of long-term sustainability and effectiveness is needed in future research, along with patient preferences.


  • Open Access

    How Do Trauma‐ and Violence‐Informed Care Approaches Underpin Bariatric Surgery Interventions for Type 2 Diabetes Mellitus Remission? A Scoping Review

    by Michelle Greenway, Michelle Domjancic, Yixuan (Claire) Liu, Alegria Benzaquen, Megan Racey, Susan M. Jack, Diana Sherifali, Carly Whitmore

    For individuals living with obesity, bariatric surgery is an effective intervention for type 2 diabetes mellitus (T2DM) remission. Given the established relationships between trauma and obesity, and obesity and T2DM, there is a need to examine bariatric surgical practices from a trauma‐ and violence‐informed care (TVIC) perspective. The purpose of this scoping review was to explore and describe the extent to which the four TVIC principles—(1) understand trauma, violence, and its impact; (2) create emotionally and physically safe environments; (3) foster opportunities for choice, collaboration, and connection; and (4) use a strengths‐based and capacity‐building approach—have been integrated into bariatric surgery processes for T2DM remission. Following the PRISMA‐ScR framework, we searched MEDLINE and EMBASE from inception to January 2024. Eligible studies included adults ≥ 18 years with T2DM undergoing bariatric surgery and reporting remission outcomes. Data were summarized narratively and charted using the TIDieR checklist. Nineteen studies were included, described in 30 publications. Despite established associations between trauma, obesity, and chronic illness, none of the included studies collected demographic data on participants' history of trauma or violence. Among included studies, mental health exclusions were common, potentially limiting access for individuals with trauma‐related mental health challenges. Our findings highlight the absence of reporting TVIC principles in bariatric surgery for T2DM remission, raising concerns about emotional safety, risks for retraumatization, and long‐term outcomes. Integrating the principles of TVIC throughout bariatric surgical care is essential to promote emotionally safe and inclusive care to enhance postoperative success and sustained health outcomes.


  • Open Access

    Missing the Target: A Scoping Review of the Use of Percent Weight Loss for Obesity Management

    by Diana Sherifali, Megan Racey, Donna Fitzpatrick‐Lewis, Michelle Greenway, Sanjeev Sockalingam, Jun Wada, Soo Huat Teoh, Ian Patton, David Macklin, Elizabeth F. C. van Rossum, et al.

    Introduction: To co‐create comprehensive targets for obesity management, we need to understand the genesis and current use of percent weight loss targets in research. The goals of our scoping review are to (1) synthesize the literature on percent weight loss targets for adults with obesity and (2) discuss the percent weight loss targets in context with their health benefits.Methods: We searched Cochrane, MEDLINE, and EMBASE for English language, pharmaceutical, and/or behavioral intervention studies in adults with obesity where the explicit aim of the study was weight reduction defined as a percent of body weight. Reviewers screened citations and extracted data including study characteristics.Results: From 16,164 abstracts, we included 30 citations which were mostly randomized controlled trials (RCTs) (n = 17) or quasi‐experimental studies (n = 12) published between 1992 and 2024. Most of the studies had target weight loss goals between 3% and 10% of body weight (n = 28), while n = 2 had body weight loss goals of 15% or 30%. The proportion of participants who met the percent weight loss target ranged from 5.9% (nutrition only study) to 85% (pharmaceutical study). The studies reported different reasons for targeting a percentage of weight loss such as disease‐specific outcomes, reduced risk of disease, or patient‐reported outcomes.Conclusion: Percent weight loss targets were based on similar research and were often not feasible nor sustainable for most participants. The design of these interventions and evaluation of obesity management would benefit from more patient‐focused parameters which could help to co‐design comprehensive targets for research and practice.


  • Open Access

    Co-Designing a postpartum diabetes prevention program after gestational diabetes mellitus: A MoSCoW prioritization workshop exercise

    by Megan Racey, Paige Alliston, Diana Sherifali, Apishanthi Sriskandarajah, Katelyn Sushko, Lorraine Lipscombe


  • Open Access

    Cystic Fibrosis–related Diabetes: A First Canadian Clinical Practice Guideline

    by Adèle Coriati, Kathryn Jane Potter, Julie Gilmour, Grace Y. Lam, Carly Nichols, Larry C. Lands, Mary-Anne Doyle, Valérie Boudreau, Laure Alexandre-Heymann, Martha L. McKinney, et al.


  • Open Access

    Peer Support for Type 2 Diabetes Management in Low- and Middle-Income Countries (LMICs): A Scoping Review

    by Diana Sherifali, Lilian Pinto Da Silva, Pooja Dewan, F. Aaysha Cader, Zainab Dakhil, Bishal Gyawali, Sheila Klassen, Israa Fadhil Yaseen, Milos Jovkovic, Saira Khalid, et al.

    Background: Although there is evidence of peer support in high-income countries, the use of peer support as an intervention for cardiometabolic disease management, including type 2 diabetes (T2DM), in low- and middle-income countries (LMICs), is unclear. Methods: A scoping review methodology was used to search the databases MEDLINE, Embase, Emcare, PsycINFO, LILACS, CDSR, and CENTRAL. Results: Twenty-eight studies were included in this scoping review. Of these, 67% were developed in Asia, 22% in Africa, and 11% in the Americas. The definition of peer support varied; however, peer support offered a social and emotional dimension to help individuals cope with negative emotions and barriers while promoting disease management. Conclusions: Findings from this scopingreview highlight a lack of consistency in defining peer support as a component of CMD management in LMICs. A clear definition of peer support and ongoing program evaluation is recommended for future research.


  • Open Access

    Technology-Supported Integrated Care Innovations to Support Diabetes and Mental Health Care: Scoping Review

    by Megan Racey, Carly Whitmore, Paige Alliston, Joseph A Cafazzo, Allison Crawford, David Castle, Rosa Dragonetti, Donna Fitzpatrick-Lewis, Milos Jovkovic, Osnat C Melamed, et al.

    Background: For individuals living with diabetes and its psychosocial comorbidities (eg, depression, anxiety, and distress), there remains limited access to interprofessional, integrated care that includes mental health support, education, and follow-up. Health technology, broadly defined as the application of organized knowledge or skill as software, devices, and systems to solve health problems and improve quality of life, is emerging as a means of addressing these gaps. There is thus a need to understand how such technologies are being used to support, educate, and help individuals living with co-occurring diabetes and mental health distress or disorder. Objective: The purpose of this scoping review was to (1) describe the literature on technology-enabled integrated interventions for diabetes and mental health; (2) apply frameworks from the Mental Health Commission of Canada and World Health Organization to elucidate the components, type, processes, and users of technology-enabled integrated interventions for diabetes and mental health; and (3) map the level of integration of interventions for diabetes and mental health. Methods: We searched 6 databases from inception to February 2022 for English-language, peer-reviewed studies of any design or type that used technology to actively support both diabetes and any mental health distress or disorder in succession or concurrently among people with diabetes (type 1 diabetes, type 2 diabetes, and gestational diabetes). Reviewers screened citations and extracted data including study characteristics and details about the technology and integration used. Results: We included 24 studies described in 38 publications. These studies were conducted in a range of settings and sites of care including both web-based and in-person settings. Studies were mostly website-based (n=13) and used technology for wellness and prevention (n=16) and intervention and treatment (n=15). The primary users of these technologies were clients and health care providers. All the included intervention studies (n=20) used technology for clinical integration, but only 7 studies also used the technology for professional integration. Conclusions: The findings of this scoping review suggest that there is a growing body of literature on integrated care for diabetes and mental health enabled by technology. However, gaps still exist with how to best equip health care professionals with the knowledge and skills to offer integrated care. Future research is needed to continue to explore the purpose, level, and breadth of technology-enabled integration to facilitate an approach to overcome or address care fragmentation for diabetes and mental health and to understand how health technology can further drive the scale-up of innovative integrated interventions.